Arthur D. Little

New technologies are changing the way pharmaceutical supply chains operate. Here, Marc Herlant, Arthur D. Little, discusses how predictive analytics offers pharmaceutical manufacturers new supply chain capabilities. Read more


In this article, Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon, Arthur D. Little, introduce a framework to guide analogue-native companies in the use of levers to manage the transition to digital. Read more

, , , Opinion

In this article, Ben van der Schaaf, principal at Arthur D. Little, gives a five-step guide to explore possible funding partnerships for lower-priority drug trials — a new model for big pharma. Read more